Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corporation filed an 8-K/A to correct its Annual Meeting results, confirming that Proposal 2 (say‑on‑pay) was approved on October 23, 2025. Shareholder participation was strong, with 195,086,461 of 217,298,626 shares outstanding and entitled to vote present and voted.
Proposal 2 received 167,126,873 For, 17,679,601 Against, 412,667 Abstain, and 9,805,786 broker non‑votes. Shareholders also ratified the appointment of BDO USA, P.C. as auditor with 181,630,320 For, 13,148,285 Against, and 307,856 Abstain. Director nominees Thierry L. Bernard, Mikhael Nassif, Avi Pelossof, and Andrea F. Wainer each received a majority of votes For.
Neogen Corporation reported results from its 2025 Annual Meeting held on October 23, 2025. A total of 195,086,461 of 217,298,626 shares outstanding and entitled to vote were represented.
Shareholders elected four directors: Thierry L. Bernard (For 168,950,135; Withheld 16,330,540), Mikhael Nassif (For 171,847,536; Withheld 13,433,139), Avi Pelossof (For 171,839,634; Withheld 13,441,041), and Andrea F. Wainer (For 169,573,203; Withheld 15,707,472).
The non-binding advisory vote on executive compensation did not pass (For 167,126,873; Against 17,679,601; Abstain 412,667; Broker Non-Vote 9,805,786). Shareholders ratified BDO USA, P.C. as independent auditor for the fiscal year ending May 31, 2026 (For 181,630,320; Against 13,148,285; Abstain 307,856).
Neogen Corp (NEOG) reported an insider equity event. On 10/13/2025, the Chief Legal Officer had 294 RSUs vest and settle into an equal number of common shares (Code M) at a stated price of $6.04 per share. To satisfy tax obligations, 115 shares were withheld/disposed (Code F) at $6.04. Following these transactions, the officer directly owns 49,851 shares.
Neogen Corp (NEOG) reported an insider equity event by a company officer (Former COO). On 10/13/2025, 783 restricted stock units vested and were settled for an equal number of common shares (transaction code M). To satisfy tax withholding, 383 shares were withheld/disposed (code F) at a price listed as $6.04 per share. Following these transactions, the reporting person directly owned 88,858 common shares.
Neogen Corp (NEOG) insider filing reports routine equity compensation activity. An officer (Former CEO) converted 3,063 restricted stock units into common stock on 10/13/2025 (Code M) at $6.04 per share, and recorded a disposition of 865 shares (Code F) at $6.04 per share the same day. After these transactions, the reporting person beneficially owned 332,849 shares, held directly.
The remarks state each RSU is the economic equivalent of one share, and these RSUs vested and were settled for an equal number of common shares on October 13, 2025.
NEOGEN CORP (NEOG) reporting person Amy M. Rocklin had 9,036 restricted stock units vest on 10/07/2025, which were settled for an equal number of shares at a recorded per-share amount of $5.63. The filing also shows a disposition of 3,534 shares on 10/07/2025 at $5.63, leaving the reporting person with 49,672 shares beneficially owned following the transactions. The transactions were signed by an attorney-in-fact on 10/09/2025.
Insider stock vesting and sale by former COO
On 10/07/2025, Douglas Edward Jones, identified as a former COO and officer of Neogen Corp (NEOG), had 12,940 restricted stock units (RSUs) vest and be settled for 12,940 shares of common stock at an indicated per‑share value of $5.63. The Form 4 shows two linked non‑derivative transactions on that date: a grant/settlement code M acquiring 12,940 shares and a disposition code F disposing of 6,329 shares at $5.63. After these reported transactions, Mr. Jones beneficially owned 88,458 shares (direct).
The filing states each RSU equals one share and that vesting and settlement occurred on 10/07/2025. The form is signed by an attorney‑in‑fact on 10/09/2025.
Insider stock activity at NEOGEN (NEOG): Former CEO and officer John Edward Adent had 32,936 restricted stock units vest on 10/07/2025, which were settled into 32,936 shares of common stock at an effective price of $5.63 per share. On the same date, 9,297 shares were disposed of at $5.63, leaving 330,651 shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 10/09/2025.
Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of common stock on 10/07/2025. The RSUs were settled at a reported per-share value of $5.63, and following the transaction the reporting person beneficially owned 15,315 shares.
The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.
Tobin James P, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest on 10/07/2025 and those RSUs were settled into 2,071 shares of common stock at a recorded price of $5.63 per share. After the settlement, the reporting person beneficially owned 39,545 shares directly. The Form 4 shows this as an acquisition resulting from compensation vesting rather than an open-market purchase.